Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heuristic is an artificial intelligence-driven drug discovery company focused on accelerating the development of novel therapeutics through advanced computational modeling. Founded by former executives from Recursion Pharmaceuticals, the company leverages a proprietary platform that integrates machine learning with biological data to identify high-potential drug candidates and optimize their development paths. Heuristic operates primarily in the pre-clinical stage, utilizing its technology to explore complex biological systems and address unmet medical needs across various therapeutic areas. The company aims to transform the traditional drug discovery paradigm by significantly reducing the time and cost associated with bringing new medicines to market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heuristic Technologies.